Medical Devices and Pharma

Medical device and pharmaceutical regulatory consulting and health safety information

Headlines

Original FDA Safety Warning for China-made Syringes

In an announcement dated November 30, 2023, the U.S. Food and Drug Administration (FDA) issued a notice regarding the evaluation of potential device failures associated with plastic syringes manufactured in China. The FDA is actively collecting and analyzing data to...

AvKARE Recalls Atovaquone Oral Suspension

AvKARE Recalls Atovaquone Oral Suspension  AvKARE, LLC has issued a voluntary recall of lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL due to potential Bacillus cereus contamination found during stability testing at a third-party lab.   The affected...

FDA Warns of Risks with OTC Pain Relief Products 

The U.S. Food and Drug Administration (FDA) has issued a stern warning to consumers regarding the use of certain over-the-counter analgesic (pain relief) products intended for topical use before, during, or after various cosmetic procedures like microdermabrasion,...

Urgent Recall Alert for Methocarbamol Injection by Eugia US LLC 

Attention Consumers, Healthcare Providers, and Distributors:  Eugia US LLC, formerly known as AuroMedics Pharma LLC, announced a voluntary recall on March 28, 2024 of lot number 3MC23011 of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) 10mL Single Dose Vial....

QMSR Design and Development – Design Inputs and Outputs

ISO 13485:2016 Design and Development Clause 7.3 - Design and DevelopmentClause 7.3.1 - GeneralClause 7.3.2 - Design and development planningClause 7.3.3 - Design and development inputsClause 7.3.4 - Design and development outputsClause 7.3.5 - Design and development...

QMSR Design and Development Controls

ISO 13485:2016 Design and Development Clause 7.3 - Design and DevelopmentClause 7.3.1 - GeneralClause 7.3.2 - Design and development planningClause 7.3.3 - Design and development inputsClause 7.3.4 - Design and development outputsClause 7.3.5 - Design and development...

ISO 9000 Clause 3 Definitions

Establishing a Common Language for Quality Management Systems ISO 9000:2015, Quality management systems — Fundamentals and vocabulary, serves as the cornerstone of the ISO 9000 family of standards, providing essential terminology and principles for quality management...

QMSR Integration

QMSR Integration The integration of FDA Quality System Regulation (QSR) requirements into ISO 13485:2016 provides a unified approach for medical device manufacturers to align with global standards while meeting U.S. regulatory requirements. The FDA's Quality...

AvKARE Recalls Atovaquone Oral Suspension

AvKARE Recalls Atovaquone Oral Suspension  AvKARE, LLC has issued a voluntary recall of lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL due to potential Bacillus cereus contamination found during stability testing at a third-party lab.   The affected...

FDA Warns of Risks with OTC Pain Relief Products 

The U.S. Food and Drug Administration (FDA) has issued a stern warning to consumers regarding the use of certain over-the-counter analgesic (pain relief) products intended for topical use before, during, or after various cosmetic procedures like microdermabrasion,...

FDA Approves Treatment for Platinum-Resistant Ovarian Cancer 

In a significant development for the treatment of platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, on March 22, 2024 the Food and Drug Administration (FDA) granted approval for mirvetuximab soravtansine-gynx, marketed as Elahere by...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

FDA Approves XACT Carotid Stent System

A Breakthrough for Stroke Prevention  Abbott Vascular Inc. has received FDA approval for its groundbreaking XACT Carotid Stent System, a significant advancement in stroke prevention technology. Approved on February 7, 2024, this innovative system offers new hope for...

FDA Approves Xolremdi for WHIM Syndrome 

A Breakthrough for Rare Infections  In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted approval for Xolremdi (mavorixafor) capsules, marking a significant milestone in the treatment of WHIM syndrome. Let's delve into what this...

FDA Approves Anktiva for Bladder Cancer 

New Drug Approval  In a significant development for patients battling BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), the Food and Drug Administration (FDA) has granted approval to nogapendekin alfa inbakicept-pmln, marketed as Anktiva by Altor...

Health Alert Regarding Rare Pregnancy Complication

FDA Safety Communication   In a recent health safety alert, the U.S. Food and Drug Administration (FDA) has cautioned healthcare professionals about the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines, including...

Latest Posts

Device Recall Alert: Edwards Lifesciences Arterial Cannula

Edwards Lifesciences Arterial CannulaSource: FDAEdwards Lifesciences Recalls Arterial Cannulae Over Risk of Exposed Wire Edwards Lifesciences has issued a Class I recall of certain arterial cannula devices due to the risk of wire exposure near the cannula tip, which...

read more

Device Recall: ZOLL AutoPulse NXT Resuscitation System

Urgent Class I Medical Device Recall ZOLL Circulation, Inc. has issued a Class I recall of its AutoPulse NXT Resuscitation System (Model 200, Software Version 2.0.1) due to a system error that may cause the device to stop chest compressions or deliver compressions...

read more

Urgent Recall of Codman Disposable Perforators

Urgent Class I Medical Device Recall Integra LifeSciences has issued an urgent recall of specific Codman Disposable Perforators and Craniotomy Kits due to a serious manufacturing defect that may lead to device disassembly during neurosurgical procedures. The FDA has...

read more

FDA Cracks Down on Insightra Medical

Warning Letter Cites a Number of Serious Violations In a scathing warning letter, the FDA has cited Insightra Medical, Inc. for widespread regulatory violations involving its Intra-Aortic Balloon Pump (IABP) Catheter Kit—a device used in critical cardiovascular...

read more

FDA Cracks Down on Illegally Marketed 7-OH Products

Unapproved drugs sold online and in retail locations  Yesterday the U.S. Food and Drug Administration (FDA) issued seven warning letters to companies marketing products that contain 7-hydroxymitragynine (7-OH) — a powerful and potentially dangerous opioid-like...

read more
Navigating the Transition from the QSR to the QMSR

Available in paperback and eBook formats on Amazon. 

Click on the image or this link to see the book on the Amazon website.

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

CDRH 2024 Safety Report

Interaction Between Regulatory and Quality Functions

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

CDRH Issues its 2024 Innovation Report

Medical Devices

Pharmaceuticals

Consumer Information

A veteran-owned business
located in
Iowa’s Cedar Valley